BCBA/JNJD (BCBA/JNJD)

Buenos Aires Stock Exchange: BCBA/JNJD · USD

$19.0

+0.05 (+0.3%)· Recorded snapshot

Market cap	995.1T
Revenue (ttm)	151.3T
Net income (ttm)	24.5T
EPS (ttm)	$675
P/E (trailing)	43.3x
P/E (forward)	23.8x
Dividend	$392 (1.34%)
Volume	2,336

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 151.3T
Net income (ttm): 24.5T
EPS (ttm): $675
P/E (trailing): 43.3x
P/E (forward): 23.8x
Market cap: 995.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.8

P25 n/aP50 n/aP75 n/a

Trailing P/E43.3

P25 n/aP50 n/aP75 n/a

ROE20

P25 n/aP50 n/aP75 n/a

ROIC21.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/JNJD indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-13
Employees	138,200
Employees change	100
Employees growth	0.07%
Enterprise value	$1037.3T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-27
First seen	2026-08-24
Fiscal year end	December
Founded	1886
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110236
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Last stock split date	2022-11-17
Last stock split type	Forward
Market cap	$995.1T
Next earnings date	2027-01-19
Price	$18.99
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/JNJD
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	46.5x
Average P/E ratio (3Y)	20.72x
Average P/E ratio (5Y)	22.21x
Earnings yield	2.31%
EV/Earnings	42.3x
EV/EBIT	25.53x
EV/EBITDA	19.43x
EV/FCF	33.07x
EV/Sales	6.79x
FCF / EV yield	3.02%
FCF yield	3.15%
Forward P/E	23.84x
Graham number	5.02467
Graham upside	-73.69%
Lynch fair value	$2.35
Lynch upside	-87.68%
P/(FCF - SBC) ratio	34.08x
P/(OCF - SBC) ratio	26.41x
P/B ratio	8.01x
P/E ratio	43.26x
P/FCF ratio	31.72x
P/OCF ratio	24.97x
P/S ratio	6.58x
Price/EBITDA ratio	18.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.59%
EBITDA margin	34.73%
Effective tax rate	9.26%
FCF margin	20.53%
Gross margin	67.77%
Operating margin	26.59%
Pretax margin	17.86%
Profit margin	16.2%
Profit per employee	$177.4M
Profitable quarters	14
Profitable years	35
Revenue per employee	$1.1B
ROA	8.46%
ROA (5Y)	8.04%
ROCE	18.6%
ROE	20.02%
ROE (5Y)	24.21%
ROIC	21.57%
ROIC (5Y)	23.67%
SBC / revenue	1.43%
Tax / revenue	1.65%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-36.37%
EPS growth (Q)	-95.89%
EPS growth (QoQ)	-96.16%
EPS growth 10Y	1.46%
EPS growth 3Y	-20.75%
EPS growth 5Y	-0.32%
EPS growth years	1
FCF growth	5.07%
FCF growth (Q)	-20.64%
FCF growth (QoQ)	-12.84%
FCF growth 3Y	9.37%
FCF growth 5Y	-1.72%
Gross profit growth	6.88%
Gross profit growth (Q)	3.56%
Gross profit growth 3Y	5.04%
Gross profit growth 5Y	1.75%
Net income growth	-35.93%
Net income growth (Q)	-95.92%
Net income growth (QoQ)	-96.21%
Net income growth 3Y	-22.54%
Net income growth 5Y	-2.08%
Net income growth years	1
OCF growth	8.08%
OCF growth (Q)	-15.8%
OCF growth (QoQ)	-10.4%
OCF growth 10Y	4.28%
OCF growth 3Y	8.86%
OCF growth 5Y	0.11%
Operating income growth	7.65%
Operating income growth (Q)	-9.78%
Operating income growth 3Y	3.06%
Operating income growth 5Y	1.65%
Revenue growth	7.8%
Revenue growth (Q)	5.86%
Revenue growth (QoQ)	0.35%
Revenue growth 10Y	3.33%
Revenue growth 3Y	5.87%
Revenue growth 5Y	1.67%
Revenue growth quarters	13
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-8.5T
Depreciation and amortization	$12.4T
EBIT	$40.2T
EBITDA	$52.6T
EPS	$675.26
Financing cash flow	$-27.7T
Free cash flow	$31.4T
Free cash flow minus SBC	$29.2T
Gross profit	$102.6T
Income taxes	$2.5T
Investing cash flow	$-14.2T
Net borrowing	$-1.2T
Net cash flow	$-2T
Net income	$24.5T
Operating cash flow minus SBC	$37.7T
Operating income	$40.2T
Revenue	$151.3T
Stock-based compensation	$2.2T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.03
Book value per share	$51,600.89
Debt / EBITDA	1.29
Debt / equity	0.55
Debt / FCF	2.17
Goodwill	$74.6T
Interest coverage	26.84
Long-term assets	$214.1T
Long-term liabilities	$91.3T
Net cash (debt)	$-41.8T
Net cash / market cap	-4.2%
Net debt / EBITDA	0.79
Net debt / equity	0.34
Net debt / FCF	1.33
Piotroski F-Score	6
Property, plant and equipment	$37.1T
Shareholders' equity	$124.2T
Tangible book value	$-20.7T
Tangible book value per share	$-8,605.74
Total assets	$300.8T
Total cash	$26.2T
Total debt	$68T
Total liabilities	$176.6T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	$86.7T
Current liabilities	$85.3T
Current ratio	1.02
Inventory turnover	2.17
Net working capital	$-11.4T
Quick ratio	0.65
Working capital	$1.4T
Working capital turnover	65,287.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.8%
Dividend growth	17.59%
Dividend growth (3Y)	8.74%
Dividend growth years	3
Dividend payment date	2026-12-09
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	$392.18
Dividend yield	1.34%
Ex-dividend date	2026-11-24
Last dividend	$0.09
Payout ratio	79.01%
Shareholder yield	0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$17.32
1D price change	0.26%
1M price change	0.26%
1M total return	0.26%
1W price change	5.11%
1W total return	5.11%
1Y price change	46.94%
1Y return CAGR	49.04%
1Y total return	49%
20-day SMA	$18.20
200-day SMA	$16.97
3M price change	2.99%
3M total return	3.31%
3Y price change	72.18%
3Y return CAGR	22.01%
3Y total return	81.66%
50-day SMA	$18.55
50-day SMA vs 200-day SMA	50over200
52-week high	$19.51
52-week high date	2026-09-03
52-week low	$12.06
52-week low date	2025-11-04
5Y price change	62.34%
5Y return CAGR	12.1%
5Y total return	76.99%
6M price change	19.87%
6M total return	20.67%
All-time high	$19.51
All-time high date	2026-09-03
All-time low	$9.20
All-time low date	2023-11-21
Average true range (ATR)	$0.53
Average volume	2.1K
Change from 52-week high	-2.67%
Change from 52-week low	57.46%
Change from all-time high	-2.92%
Change from all-time low	105.87%
Change from open	-0.37%
Day's gap	0.63%
Dollar volume	$44,361
High price	$19.20
Low price	$18.91
Monthly RSI	75.72
Open price	$19.06
Position in 52-week range	27.59%
Previous close	$18.94
Price vs 150-day SMA	9.38%
Price vs 20-day SMA	4.07%
Price vs 200-day SMA	11.58%
Price vs 50-day SMA	2.11%
Relative volume	1.13
RSI	59.01
Sharpe ratio	1.65
Sharpe ratio (3Y)	0.6
Sortino ratio	2.83
Sortino ratio (3Y)	1.08
Volume	2.3K
Weekly RSI	60.88
YTD price change	32.91%
YTD total return	34.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.4B
Shares change (QoQ)	0.35%
Shares change (YoY)	0.8%
Shares held by insiders	0.04%
Shares held by institutions	76.32%
Short ratio	2.4 days

Deeper analysis on BCBA/JNJD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/JNJD report

Is a complete BCBA/JNJD research report available?

No complete published report is available for bcba/JNJD (BCBA/JNJD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/JNJD (BCBA/JNJD)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/JNJD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/JNJD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/JNJD

Frequently asked questions